Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine in patients undergoing radical lung cancer surgery
ChiCTR2300070910Phase 4Recruiting
- Sponsor
- Department of Anesthesiology, Affiliated Hospital of Southwest Medical University
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esketamine in bronchial carcinoma (2 arms), sponsored by Department of Anesthesiology, Affiliated Hospital of Southwest Medical University. Primary endpoints: PHQ-9 scale score and Intestinal flora. Started Jan 2022; status: recruiting.
02
Drugs
esketamine
03
Conditions
bronchial carcinoma
Beyond the preview
Go deeper on ChiCTR2300070910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300070910.